asp015k
Showing 1 - 16 of 16
Patients With Impaired Renal Function Trial in Tokyo (ASP015K)
Completed
- Patients With Impaired Renal Function
- ASP015K
-
Tokyo, Japan
- +1 more
Apr 5, 2019
Patients With Impaired Hepatic Function Trial in Fukuoka, Kanagawa, Tokyo (ASP015K)
Completed
- Patients With Impaired Hepatic Function
- ASP015K
-
Fukuoka, Japan
- +5 more
Apr 5, 2019
Healthy Volunteers, Pharmacokinetics of ASP015K Trial in Glendale (ASP015K, Placebo)
Completed
- Healthy Volunteers
- Pharmacokinetics of ASP015K
- ASP015K
- Placebo
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group/Parexel
Jun 2, 2014
Healthy Subjects, Pharmacokinetics of ASP015K Trial in Glendale (ASP015K, verapamil)
Completed
- Healthy Subjects
- Pharmacokinetics of ASP015K
- ASP015K
- verapamil
-
Glendale, CaliforniaPAREXEL
Apr 7, 2014
Healthy Subjects, Pharmacokinetics of ASP015K Trial in Glendale (ASP015K, Rosuvastatin)
Completed
- Healthy Subjects
- Pharmacokinetics of ASP015K
- ASP015K
- Rosuvastatin
-
Glendale, CaliforniaPAREXEL - Early Phase Unit
Oct 8, 2013
Bioavailability of ASP015K, Healthy Subjects, Pharmacokinetics of ASP015K Trial in Baltimore (ASP015K)
Completed
- Bioavailability of ASP015K
- +3 more
- ASP015K
-
Baltimore, MarylandParexel - Early Phase Clinical Unit
Sep 13, 2013
Bioavailability of ASP015K, Pharmacokinetics of ASP015K, Healthy Subjects Trial in Dallas (ASP015K)
Completed
- Bioavailability of ASP015K
- +2 more
- ASP015K
-
Dallas, TexasCovance
Dec 2, 2011
Pharmacokinetics of ASP015K, Bioavailability of ASP015K, Healthy Subjects Trial in Glendale (ASP015K)
Completed
- Pharmacokinetics of ASP015K
- +2 more
- ASP015K
-
Glendale, CaliforniaPAREXEL
Dec 1, 2011
Healthy Trial in Ruddington (ASP015K)
Completed
- Healthy
- ASP015K
-
Ruddington, Nottingham, United KingdomQuotient Clinical Limited
Sep 6, 2011
Pharmacokinetics of ASP015K, Drug Interactions, Healthy Subjects Trial in Miami (ASP015K, Tacrolimus)
Completed
- Pharmacokinetics of ASP015K
- +2 more
- ASP015K
- Tacrolimus
-
Miami, FloridaClinical Pharmacology of Miami
Sep 6, 2011
Healthy Subjects, Pharmacokinetics of ASP015K Trial in Madison (ASP015K)
Completed
- Healthy Subjects
- Pharmacokinetics of ASP015K
- ASP015K
-
Madison, WisconsinCovance Clinical Research Unit (CCRU)
Jul 28, 2011
Healthy Subjects, Pharmacokinetics of ASP015K Trial in Miami, St. Paul (ASP015K, Placebo)
Completed
- Healthy Subjects
- Pharmacokinetics of ASP015K
- ASP015K
- Placebo
-
Miami, Florida
- +1 more
Jun 30, 2011
Healthy Subjects, Pharmacokinetics of ASP015K, Pharmacodynamics Trial in Minneapolis (ASP015K, Placebo)
Completed
- Healthy Subjects
- +2 more
- ASP015K
- Placebo
-
Minneapolis, MinnesotaDaVita Clinical Research
Jun 1, 2011
Healthy Subjects, Drug Interactions, Pharmacokinetics of ASP015K Trial in Miami (ASP015K, Mycophenolate Mofetil)
Completed
- Healthy Subjects
- +2 more
- ASP015K
- Mycophenolate Mofetil
-
Miami, FloridaClinical Pharmacology of Miami
Jun 1, 2011
Healthy, Pharmacokinetics of ASP015K and Tacrolimus Trial in Honolulu (Tacrolimus, ASP015K)
Completed
- Healthy
- Pharmacokinetics of ASP015K and Tacrolimus
- Tacrolimus
- ASP015K
-
Honolulu, Hawaii(unnamed)
Oct 12, 2010
Healthy, Pharmacokinetics of ASP015K and Midazolam Trial in Miami (ASP015K, Midazolam)
Completed
- Healthy
- Pharmacokinetics of ASP015K and Midazolam
- ASP015K
- Midazolam
-
Miami, Florida(unnamed)
Aug 11, 2010